Veru, Inc. (VERU)
2.645
-0.10
(-3.82%)
USD |
NASDAQ |
Sep 03, 16:00
2.645
0.00 (0.00%)
After-Hours: 20:00
Veru Cash from Investing (Quarterly) : 1.802M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.802M |
| March 31, 2026 | 3.520M |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 6.276M |
| June 30, 2025 | 0.4741M |
| March 31, 2025 | 1.148M |
| December 31, 2024 | 17.25M |
| September 30, 2024 | 0.1315M |
| June 30, 2024 | 0.0554M |
| March 31, 2024 | -0.0407M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.7871M |
| June 30, 2023 | 5.974M |
| March 31, 2023 | -0.1416M |
| December 31, 2022 | -0.2856M |
| September 30, 2022 | -0.1488M |
| June 30, 2022 | 2.403M |
| March 31, 2022 | -0.1852M |
| December 31, 2021 | 2.198M |
| September 30, 2021 | -0.2222M |
| June 30, 2021 | -0.1423M |
| March 31, 2021 | -0.0049M |
| December 31, 2020 | 14.99M |
| September 30, 2020 | -0.0323M |
| June 30, 2020 | -0.0188M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0329M |
| December 31, 2019 | -0.0218M |
| September 30, 2019 | -0.0336M |
| June 30, 2019 | -0.0743M |
| March 31, 2019 | -0.0006M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.003M |
| June 30, 2018 | -0.0458M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.0019M |
| September 30, 2017 | 0.0291M |
| June 30, 2017 | -0.0359M |
| March 31, 2017 | -0.0179M |
| December 31, 2016 | -0.0656M |
| September 30, 2016 | -0.0029M |
| June 30, 2016 | -0.0007M |
| March 31, 2016 | 0.0002M |
| December 31, 2015 | -0.0029M |
| September 30, 2015 | -0.0078M |
| June 30, 2015 | -0.1005M |
| March 31, 2015 | -0.0248M |
| December 31, 2014 | -0.0023M |
| September 30, 2014 | -0.0104M |
| June 30, 2014 | -0.0029M |
| March 31, 2014 | -0.0021M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Johnson & Johnson | -1.11B |
| Eli Lilly & Co. | -15.40B |
| Lexicon Pharmaceuticals, Inc. | -16.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.467M |
| Cash from Financing (Quarterly) | -0.0519M |
| Free Cash Flow | -26.04M |
| Free Cash Flow Per Share (Quarterly) | -0.2372 |
| Free Cash Flow to Equity (Quarterly) | -5.317M |
| Free Cash Flow to Firm (Quarterly) | -5.467M |
| Free Cash Flow Yield | -48.59% |